P122 A multicenter study of epirubicin-docetaxel (ET) as primary chemotherapy for patients with inflammatory breast cancer (IBC)
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI